Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Dear Sir / Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed herewith transcript of the Earning Call held on May 25,2022 wherein the management of the Company discussed the Q4FY2022 Results. The same has also been uploaded on the Company's website and the same can be accessed at www.metropolisindia.com. This is for your information and records.
31-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Sub: Annual Secretarial Compliance Report of the Company for the financial year ended March 31, 2022 Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019; we are enclosing herewith the Annual Secretarial Compliance Report of the Company for the financial year ended March 31, 2022, issued by M/s. RM Shah & Co., Practicing Company Secretaries. Request you to kindly take the above information on record and oblige.
29-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sir/Madam, This is to inform you that the Board of Directors of the Company in its meeting held on May 24, 2022 has approved the audited Standalone and Consolidated Financial Statements of the Company for the quarter and year ended March 31, 2022. In this regard and pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein enclose the copy of the Newspaper Advertisement dated May 26, 2022 published in the following newspapers: 1. Free Press Journal (English) 2. Navshakti (Marathi) This is for your information and record.
26-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 This is further to our letter having Reference No: MHL/Sec&Legal/2021-22/12 dated May 18, 2022 with respect to Intimation of Earnings Call for the quarter ended March 31, 2022 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 the audio recording of the earnings call held on May 25, 2022 to discuss the Q4FY22 Results and Future outlook of the Company, is available on the Company's website under the below link: https://www.metropolisindia.com/newdata/Investors/Financials/22-23/Q1/MHLQ4% 20&%20FY22%20Earnings%20Call%20Audio.mp3
25-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 With reference to the captioned subject, we wish to inform you that the Board of Directors of the Company at its meeting held on May 24, 2022, upon the recommendation of Nomination and Remuneration Committee, considering the talent retention measure and in order to align the employees with the long term interests of the Company, has approved the revised pool size of Restrictive Stock Units (RSUs) under the Metropolis - Restrictive Stock Unit Plan - 2020 (MHL - RSU Plan 2020/RSU Plan) by way of addition of 1,00,000 (One Lakh) RSUs, thereby the revised pool size of RSUs under the Metropolis - Restrictive Stock Unit Plan - 2020 (MHL - RSU Plan 2020) shall stand increase from 2,70,000 (Two Lakh Seventy Thousand) to 3,70,000 (Three Lakh Seventy Thousand ) RSUs and other consequential amendment to RSU plan in order to align the said plan with the applicable SEBI Regulation.
25-05-2022
Bigul

Q4FY22 Quarterly Result Announced for Metropolis Healthcare Ltd.

 Metropolis Healthcare declares Q4FY22 result: Metropolis Healthcare Ltd. recorded highest ever Revenue, EBITDA & PAT in FY22 Patient visits increased by 37% on YoY basis to 13.4 Mn in FY22 No. of tests increased by 35% on YoY basis to 25.7 Mn in FY22 Non-Covid Home Visits revenue increased by 23% YoY Rs. 98 Crs. Rs.1,228 Crs. Revenue up +23% YoY Rs. 362 Crs. EBITDA (Before CSR, ESOP & One-time acquisition cost) +20% YoY 29.4% EBITDA Margin (Before CSR, ESOP & Onetime acquisition cost) “I am extremely pleased to share that inspite of all the challenges faced on account of covid led supply chain disruptions, we were able to record our highest ever Revenue, EBITDA & PAT in FY22. Strong performance was on the back of robust growth in the sustainable non-covid business. During the year, we have made significant investments in digital, marketing, widening of leadership team and expansion of service network. These investments we make now will enable us to create a backbone for the next level of growth that we envisage in the business and help us safeguard our margins keeping in view the increased competitive intensity in coming times. Going ahead, we will continue to build the brand on scientific basis, invest in core focus areas and on the acquisition front, drive the synergies at Hitech through quick & smooth integration.” Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Ltd. Result PDF
25-05-2022
Bigul

Annual report for Metropolis Healthcare Ltd. for FY-2022
25-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Grant Of Rsus Pursuant To The Metropolis - Restrictive Stock Unit Plan - 2020 (MHL - RSU Plan 2020)

 We wish to inform you that the Nomination and Remuneration Committee of the Board of Directors of the Company at its meeting held today has approved the grant of 28,800 Restricted Stock Units pursuant to the Metropolis - Restrictive Stock Unit Plan - 2020 (MHL - RSU Plan 2020) to the eligible employees of the Company/ Subsidiary(ies).
24-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Dear Sir / Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a copy of the Investor Presentation for the quarter and year ended March 31, 2022. You are requested to take the above information on record. This is for your information and record. Thanking you,
24-05-2022
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Dear Sir / Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations, 2015, we are enclosing herewith a Press Release as mentioned below: Metropolis Healthcare Ltd. recorded highest ever Revenue, EBITDA & PAT in FY22 You are requested to take the above information on record This is for your information and record. Thanking you
24-05-2022
Next Page
Close

Let's Open Free Demat Account